Trafficking Protein Particle Complex Subunit 2 (TRAPPC2) Antibody
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
TRAPPC2 Antibody is a Rabbit Polyclonal against TRAPPC2.
Documents del producto
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | Trafficking Protein Particle Complex Subunit 2 (TRAPPC2) |
| Host | Rabbit |
| Reactivity | Human |
| Recommended Dilution | ELISA: 1 µg/ml, WB: 1/500 - 1/2000. Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Unconjugated |
| Isotype | IgG |
| Purification | Purified by affinity chromatography. |
| Size 1 | 20 µl |
| Size 2 | 100 µl |
| Size 3 | 2 × 100 µl |
| Form | Liquid |
| Tested Applications | ELISA, WB |
| Buffer | PBS, pH 7.3, containing 0.02% sodium azide, 50% glycerol. |
| Availability | Shipped within 5-10 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| UniProt ID | P0DI81 |
| Gene ID | 6399 |
| NCBI Accession | NP_055378.1 |
| Background | Antibody anti-TRAPPC2 |
| Status | RUO |
| Note | Concentration: > 0.2 mg/ml - |
Descripción
Related Products
TRAPPC2 antibody
TRAPPC2 is one component of the TRAPP multisubunit tethering complex involved in intracellular vesicle trafficking [PMID:21525244]. It acts as an adaptor for the TRAPP complex in mammalian cells, mediating interactions with both TRAPPC9 and TRAPPC8. It prevents transcriptional repression and induction of cell death by ENO1. Also it plays a role in vesicular transport from endoplasmic reticulum to Golgi.
Ver Producto
Recombinant Human TRAPPC2
Ver Producto
Trafficking Protein Particle Complex Subunit 2 (TRAPPC2) Antibody
TRAPPC2 is thought to be part of a large multi-subunit complex involved in the targeting and fusion of endoplasmic reticulum-to-Golgi transport vesicles with their acceptor compartment. In addition, the encoded protein can bind c-myc promoter-binding protein 1 and block its transcriptional repression capability. Mutations in this gene are a cause of spondyloepiphyseal dysplasia tarda (SEDT). A processed pseudogene of this gene is located on chromosome 19, and other pseudogenes are found on chromosomes 8 and Y.
Ver Producto